AVALON GLOBOCARE CORP.

Profile

Company Names

AVALON GLOBOCARE CORP.

Addresses

4400 ROUTE 9, SUITE 3100, FREEHOLD, NJ 07728

83 SOUTH STREET, SUITE 101, FREEHOLD, NJ 07728

Phone Numbers

646-762-4517
(646) 762-4517

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$12,735,000.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2026-02-27 
$3,250,000.00 
$3,250,000.00 
$0.00 
Equity 
3
2023-10-09 
$700,000.00 
$700,000.00 
$0.00 
 
2
2017-10-20 
$5,150,000.00 
$5,150,000.00 
$0.00 
Equity 
1
2016-12-19 
$3,635,000.00 
$4,000,000.00 
$365,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LOURDES 
 
FELIX 
DIRECTOR
BIOCORRX INC.   |  SIYATA MOBILE INC.   |  FUNCTIONAL BRANDS INC.   |  LA ROSA HOLDINGS CORP.   |  AVALON GLOBOCARE CORP.
LUISA 
 
INGARGIOLA 
EXECUTIVE OFFICER
MAGNEGAS CORP   |  FTE NETWORKS, INC.   |  COPSYNC, INC.   |  AVALON GLOBOCARE CORP.   |  NEXION BIOSCIENCES INC   |  ELECTRAMECCANICA VEHICLES CORP.   |  AGEAGLE AERIAL SYSTEMS INC.   |  NEXT RENEWABLE FUELS, INC.   |  VISION MARINE TECHNOLOGIES INC.   |  LAKEVIEW RNG, LLC   |  DRAGONFLY ENERGY HOLDINGS CORP.   |  FUSION FUEL GREEN PLC
DAVID 
 
JIN 
EXECUTIVE OFFICER, DIRECTOR
AVALON GLOBOCARE CORP.   |  AVENUE THERAPEUTICS, INC.
DAVID 
K 
JIN 
EXECUTIVE OFFICER, DIRECTOR
AVALON GLOBOCARE CORP.
MENG 
 
LI 
EXECUTIVE OFFICER, DIRECTOR
AVALON GLOBOCARE CORP.
WENZHAO 
 
LU 
DIRECTOR
AVALON GLOBOCARE CORP.
YANCEN 
 
LU 
DIRECTOR
AVALON GLOBOCARE CORP.   |  511 THERAPEUTICS, INC.
MICHAEL 
 
MATHEWS 
DIRECTOR
5TO1 HOLDING CORP.   |  ASPEN UNIVERSITY, INC.   |  WIZARD WORLD, INC.   |  ASPEN GROUP, INC.   |  AUXILIO INC   |  AVALON GLOBOCARE CORP.
STEVEN 
A. 
SANDERS 
DIRECTOR
OP TECH ENVIRONMENTAL SERVICES INC   |  AVALON GLOBOCARE CORP.
STEVEN 
 
SUKEL 
DIRECTOR
AVALON GLOBOCARE CORP.
WILBERT 
J 
TAUZIN II 
DIRECTOR
AVALON GLOBOCARE CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-12
D
Link
OTHER TECHNOLOGY 
SERVICES-COMPUTER PROGRAMMING SERVICES [7371] 
DECLINE TO DISCLOSE 
Equity 
2026-02-27 
2023-10-20
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$25,000,001 - $100,000,000 
 
2023-10-09 
2017-12-19
D
Link
OTHER HEALTH CARE 
SERVICES-MANAGEMENT CONSULTING SERVICES [8742] 
DECLINE TO DISCLOSE 
Equity 
2017-10-20 
2016-12-21
D
Link
OTHER HEALTH CARE 
SERVICES-MANAGEMENT CONSULTING SERVICES [8742] 
DECLINE TO DISCLOSE 
Equity 
2016-12-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
000000375
NONE
NONE
REVERE SECURITIES LLC
14178